SCHEMBL27612456

SCHEMBL27612456

COC(=O)c1ccc(-c2nc(N)nc(N)c2F)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NEK2 P51955 5/20 0.46
▸ GAA P10253 2/20 0.44
▸ PIK3CA P42336 1/20 0.43
▸ CHEK1 O14757 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ DHFR P00374 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612710 0.89 NEK2 (0.58) NEK2CHEK1KDM4EDHFRMKNK1
SCHEMBL2849165 0.86 GAA (0.51) GAAKDM4ENPC1CASP3RAB9A
SCHEMBL27612634 0.84 CA12 (0.47) GAAKDM4ENPC1CASP3RAB9A
SCHEMBL27631564 0.81 DHFR (0.52) PIK3CAKMT2AKDM4EDHFRALDH1A1
SCHEMBL27612534 0.81 MBOAT4 (0.43) GAAKMT2ANPC1CASP3RAB9A
SCHEMBL27631625 0.81 NEK2 (0.46) NEK2KDM4ERAB9ADHODHDHFR
SCHEMBL27612368 0.79 DHFR (0.51) GAAKMT2AKDM4ENPC1RAB9A
SCHEMBL188522 0.78 DHODH (0.52) NEK2PIK3CAKMT2AKDM4ESMN1; SMN2
SCHEMBL27631926 0.78 PIK3CG (0.48) GAAPIK3CAKMT2AKDM4ENPC1
SCHEMBL27612648 0.77 DHFR (0.54) NPC1RAB9ADHFRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
Send feedback